Category: COVID-19 23 March 2020
Accelero received needed permits for processing SARS-CoV-2 in biological samples and works on antibody detection
Accelero Bioanalytics GmbH has received the authority permit for processing and analysis of SARS-CoV-2 in biological samples. The Berlin State Office for Occupational Safety, Health Protection, and Technical Safety (LAGetSi) as well as the local Health Department in Treptow-Köpenick both allowed the processing and analysis of upper and lower respiratory specimen (swaps, sputum, bronchoalveolar lavage) via SARS-CoV-2 specific RTqPCR assays.
The company will also work on immunological assays for innate immune response monitoring like IgG and/or IgM detection and titer determination against SARS-CoV-2 in human serum.
Accelero can also provide FluoroSpot assays for direct and sensitive detection of IgG secreting cells in response to SARS-CoV-2 stimulation in vitro. All services will be provided in full compliance with GLP regulations.
NOT FOR DIAGNOSTIC USE – FOR INFORMATION PURPOSES ONLY.